PRIA Healthcare Announces the Acquisition of Argenta Advisors, Expanding Market Access and Reimbursement Expertise

PRIA Healthcare • October 8, 2024
PRIA Healthcare Argenta Advisors Acquisition Announcement

Torrington, CT – October 8, 2024 – PRIA Healthcare, a leader in innovative patient access and reimbursement services, is proud to announce the acquisition of Argenta Advisors, a renowned consulting firm specializing in market access and reimbursement strategy. The acquisition, finalized on September 1, 2024, represents a significant step in PRIA Healthcare’s mission to enhance its comprehensive suite of services and further support medical technology companies in navigating the complexities of the healthcare landscape.


Co-founded in 2001 by Louise Guy, a registered nurse with decades of experience in healthcare delivery, Argenta Advisors has built a strong reputation as a trusted partner in the field of reimbursement. With a team that includes physicians, nurses, certified coders, and reimbursement experts, Argenta offers deep expertise across the reimbursement continuum. Their strategic approach has led to the successful launch of numerous medical technologies, securing coding, coverage, and payment across all payer types.


Joining forces with PRIA Healthcare is a natural progression for Argenta Advisors,” said Louise Guy, Managing Partner and Co-founder of Argenta Advisors. “Our shared commitment to actionable strategies and dedication to advancing patient access to innovative medical technologies make this partnership a perfect fit. We look forward to combining our strengths to better serve our clients and the healthcare industry.


Louise’s leadership and extensive background in clinical care, strategic business planning, and reimbursement have been instrumental in Argenta’s success. Her experience spans roles in biotechnology, health insurance, and medical technology, giving her a unique perspective on the challenges of commercialization and adoption in the healthcare sector.


“It has been an incredible honor to collaborate with Louise Guy over the years,” said Tonya Dowd, Executive Vice President of Reimbursement, Value Generation, and Market Access at PRIA Healthcare. “Her unwavering commitment to advancing patient access to innovative medical technologies, combined with her deep expertise in healthcare delivery and reimbursement, has set a gold standard in our industry. Louise’s ability to navigate the most complex challenges with compassion and precision is truly inspiring. As we embark on this next chapter together, I am committed to carrying forward her legacy of excellence and relentless advocacy for patient care.”


PRIA Healthcare’s Expansion


This acquisition aligns with PRIA Healthcare’s ongoing strategy to expand its capabilities in delivering data-driven, patient-centric solutions. PRIA Healthcare’s service offerings include services to support patient access to new and novel technologies during a period of reimbursement uncertainty. Offering benefits verification, prior authorization, appeals management, and patient access program analytics, all powered by a centralized, HIPAA-compliant platform . The addition of Argenta Advisors strengthens PRIA Healthcare’s position as a leader in providing comprehensive market access solutions that address the full lifecycle of medical technology products.


“We are thrilled to welcome Argenta Advisors to the PRIA Healthcare family,” said Jeff Sirek, CEO of PRIA Healthcare. “Argenta’s exceptional track record and deep industry knowledge will be invaluable as we continue to support our clients in overcoming reimbursement challenges and ensuring patient access to life-changing technologies. Looking ahead, our combined expertise positions us to lead the charge in accelerating healthcare innovation, driving successful outcomes from concept to commercialization.”


The combined expertise of PRIA Healthcare and Argenta Advisors will offer unparalleled support to clients seeking durable and predictable reimbursement pathways. Together, they are well-positioned to drive successful outcomes for innovative medical technologies, from concept to commercialization.


About PRIA Healthcare PRIA Healthcare is a full-spectrum reimbursement services firm based in Connecticut. Since 2012, PRIA Healthcare has been vital to the successful commercialization of over 250 medical devices, partnering with innovators in MedTech and Life Science. PRIA’s renowned experts in reimbursement strategy and healthcare economics navigate challenging reimbursement pathways, determining coding, coverage, and payment for market access and the adoption of new technologies. PRIA supports the entire product journey of healthcare innovations from concept through commercialization.


For more information about PRIA Healthcare and its portfolio of services, please visit www.priahealthcare.com

If you’re a medical device innovator, I’d love to hear from you. What reimbursement and market access challenges—or questions—keep you up at night?

Contact PRIA Healthcare to Learn More >>

Click the Icon below to share this with your network

You Got Your 510(k). Now What?
By Suzy Engwall May 28, 2026
You Got Your 510(k). Now What?
Right Sizing Your Quality System by Sam Murray
By Sam Murray, Head of Regulatory & Quality May 21, 2026
Right Sizing Your Quality System
Cleared for takeoff: Insights from a Medtech First Officer
By Suzy Engwall May 19, 2026
Five Mistakes MedTech StartUps Make Before Their First VAC Meeting
Using Regulatory as a Strategy and Not a Milestone
By Sam Murray, PRIA May 14, 2026
Using Regulatory as a Strategy and Not a Milestone
Reading the Water: Navigating What Matters in Regulatory and Quality  - Sam Murray, PRIA
By Sam Murray, Head of Regulatory & Quality May 6, 2026
An informative article series from PRIA Healthcare's Head of Regulatory and Quality, Sam Murray
Medical device strategy CMS/FDA RAPID program
April 24, 2026
PRIA examines the impact of the RAPID program, accelerating Medicare access for Breakthrough Devices by aligning FDA approval & CMS coverage, earlier, on innovators.
MedTech Clinical Evidence Strategy
By PRIA Healthcare April 20, 2026
PRIA's experts on reimbursement and regulatory issues weigh in on CMS's proposed NTAP change, and what it may mean for MedTech innovations.
PRIA Healthcare welcomes Sam Murray as Head of Regulatory and Quality Services
March 10, 2026
PRIA Healthcare is thrilled to announce that Sam Murray has joined PRIA as our Head of Regulatory and Quality. Sam brings more than a decade of experience doing exactly that kind of high-stakes, high-impact regulatory work across medical devices, diagnostics, combination products, and software-enabled technologies.
PRIA a strategic and execution partner for reimbursement and market access
By Tonya Dowd, MPH, Executive Vice President, Reimbursement, Health Economics, Market Access and Corporate Development February 23, 2026
MedTech reimbursement and market access, core drivers of valuation, acquisition potential, and long-term viability, should be developed in sync with your regulatory strategy
PRIA's H2 Newsletter - PRIA Pages
By Nancy Bax December 23, 2025
PRIA's Second Quarter in Review
PRIA is proud to support LSI in 2026
By Nancy Bax November 6, 2025
Continuing and Strengthening our Relationship with a Vital Industry Event
PRIA helps clients navigate the challenging MedTech market access landscape
By Nancy Bax October 21, 2025
A leader in Reimbursement & Market Access Services, PRIA has followed developments on WISeR. Here is our summary of the new CMS Provider & Supplier Operational Guide